Rx Rundown: AbbVie, Eli Lilly, Roche and more
Check out this week’s medical marketing news, dealmaking and industry chatter.
Source: mmm-online.com
Asher Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Asher Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Asher Bio Today - Breaking & Trending Today
BNT211 With or Without CARVac Shows Early Activity in CLDN6+ R/R Advanced Solid Tumors
The Claudin-6–directed CAR T-cell therapy, BNT211, showed signs of clinical activity in patients with CLDN6-positive relapsed or refractory solid tumors.
Source: onclive.com
Top Life Sciences Startups to Watch in 2023
BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.
Source: biospace.com
Sanofi hits reset on drug from $2.5B deal after 'lower than projected' efficacy in trials
Sanofi did not see the efficacy it wanted in mid-stage tests of a cytokine therapy from its $2.5 billion acquisition of Synthorx. While the pharmaceutical giant isn’t giving up on the drug, it said it will restart the molecule in a new Phase 1/2 program, a setback that will lead to a €1.6 billion financial writedown.
Source: medcitynews.com
Asher Bio Appoints Andrea Pirzkall, M.D., as Chief Medical Officer
Industry veteran brings deep expertise in translational medicine and clinical development in oncologySAN FRANCISCO--(BUSINESS WIRE)--Asher Biotherapeutics, Inc. (Asher Bio), a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, today announced the appo...
Source: pharmiweb.com